WWHS

Founded in 2016, WWHS Biotech.Inc is a high-tech company incubated by the Research Institute of Tsinghua University in Shenzhen. The company is a wholly owned subsidiary of Sansure Biotech Inc. (Stock Code: 688289).

The company has pioneered IR-LF (infrared fluorescence lateral flow) technology based on infrared fluorescent nanobeads, enabling rapid and quantitative point-of-care testing (POCT). This innovation marks a major breakthrough in the POCT field and represents a first-of-its-kind technology globally.

To date, WWHS has obtained over 10 inventions and utility model patents, over 20 NMPA registrations in China, and more than 60 products with CE marking. Its products are widely used in clinical settings for immunofluorescence testing of common and high-incidence diseases, as well as in primary healthcare for chronic disease management and early disease detection.